TRAW — Traws Pharma Balance Sheet
0.000.00%
- $10.92m
- -$5.47m
- $0.23m
Annual balance sheet for Traws Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 22.7 | 19 | 55.1 | 38.8 | 20.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.098 | 0.037 | 0.028 | 0.029 | 0.018 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 23.5 | 19.8 | 55.4 | 39.3 | 22.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.05 | 0.052 | 0.038 | 0.024 | 0.022 |
Other Long Term Assets | |||||
Total Assets | 23.7 | 20 | 55.5 | 39.4 | 22.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.29 | 10 | 6.12 | 8.05 | 9.22 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 12.1 | 13.8 | 9.36 | 11.1 | 12 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 11.6 | 6.17 | 46.1 | 28.3 | 10.7 |
Total Liabilities & Shareholders' Equity | 23.7 | 20 | 55.5 | 39.4 | 22.7 |
Total Common Shares Outstanding |